Doose syndrome (myoclonic-astatic epilepsy): 40 years of progress

Developmental Medicine and Child Neurology

Volumn 52, Issue 11, 2010, Pages 988-993

  Kelley, Sarah A ^a   Kossoff, Eric H ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLONAZEPAM; CORTICOTROPIN; DEXAMETHASONE; ETHOSUXIMIDE; ETIRACETAM; LAMOTRIGINE; PHENYTOIN; PREDNISONE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DOOSE SYNDROME; DRUG EFFICACY; DRUG MEGADOSE; ELECTROENCEPHALOGRAM; FEBRILE CONVULSION; GENE MUTATION; GENERALIZED EPILEPSY; HUMAN; KETOGENIC DIET; MYOCLONIC ASTATIC EPILEPSY; NERVOUS SYSTEM DEVELOPMENT; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SPIKE WAVE; TREATMENT OUTCOME;

ANTICONVULSANTS; ELECTROENCEPHALOGRAPHY; EPILEPSIES, MYOCLONIC; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MUTATION; NEUROPEPTIDES; PROGNOSIS; RECEPTORS, GABA-A; SODIUM CHANNELS;

EID: 78649439572     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2010.03744.x     Document Type: Review

References (27)

1. Hunt JR. On the occurrence of static seizures. J Nerv Ment Dis 1922; 56: 351-6.
2. Gastaut H, Roger J, Soulayrol R, et al. Childhood epileptic encephalopathy with diffuse slow spike-waves (otherwise known as 'petit mal variant') or Lennox syndrome. Epilepsia 1966; 7: 139-79.
3. Krause R. Das Myoklonisch-Astatische Petit Mal [Myoclonic-astatic petit mal]. Berlin: Springer Press, 1968. (In German).
4. Doose H, Gerken H, Leonhardt R, Volzke E, Volz C. Centrencephalic myoclonic-astatic petit mal. Clinical and genetic investigations. Neuropediatrie 1970; 2: 59-78. (In German)
5. Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE commission on classification and terminology, 2005-2009. Epilepsia 2010; 51: 676-85.
6. Neubauer BA, Hahn A, Doose H, Tuxhorn I. Myoclonic-astatic epilepsy of early childhood - definition, course, nosography and genetics. Adv Neurol 2005; 95: 147-55.
7. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989; 30: 389-99.
8. Ewen J, Comi A, Kossoff E. Myoclonic-astatic epilepsy in a child with Sturge-Weber syndrome. Pediatr Neurol 2007; 36: 115-7.
9. Oguni H, Fukuyama Y, Tanaka T, et al. Myoclonic-astatic epilepsy of early childhood - clinical and EEG analysis of myoclonic-astatic seizures, and discussions of the nosology of the syndrome. Brain Dev 2001; 23: 757-64.
10. Oguni H, Tanaka T, Hayashi K, et al. Treatment and long-term prognosis of myoclonic-astatic epilepsy of early childhood. Neuropediatrics 2002; 33: 122-32.
11. Doose H. Myoclonic-astatic epilepsy. Epilepsy Res 1992; 6 (Suppl.) 163-8.
12. Scheffer I. Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. Brain 1997; 120: 479-90.
13. Dimova P, Yordanova I, Bojinova V, Jordanova A, Kremenski I. Generalized epilepsy with febrile seizures plus: Novel SCN1A mutation. Pediatr Neurol 2010; 42: 137-40.
14. Ebach K, Joos H, Doose H, et al. SCN1A mutation analysis in myoclonic astatic epilepsy and severe idiopathic generalized epilepsy of infancy with generalized tonic-clonic seizures. Neuropediatrics 2005; 36: 210-3.
15. Nabbout R, Kolovski A, Gennaro E, et al. Absence of mutations in major GEFS+ genes in myoclonic astatic epilepsy. Epilepsy Res 2003; 56: 127-33.
16. Jeavons PM, Clark JE, Maheshwari MC. Treatment of generalized epilepsies of childhood and adolescence with sodium valproate. Dev Med Child Neurol 1977; 19: 9-25.
17. Kilaru S, Bergqvist AG. Current treatment of myoclonic astatic epilepsy: clinical experience at the Children's Hospital of Philadelphia. Epilepsia 2007; 48: 1703-7.
18. Jayawant S, Libretto SE. Topiramate in the treatment of myoclonic-astatic epilepsy in children: a retrospective hospital audit. J Postgrad Med 2003; 49: 202-6.
19. Dulac O, Kaminska A. Use of lamotrigine in Lennox-Gastaut and related epilepsy syndromes. J Child Neurol 1997; 12: S23-8.
20. Wallace SJ. Myoclonus and epilepsy in childhood: a review of treatment with valproate, ethosuximide, lamotrigine and zonisamide. Epilepsy Res 1998; 29: 147-54.
21. Labate A, Colosimo E, Gambardella A, Leggio U, Ambrosia R, Quattrone A. Levetiracetam in patients with generalized epilepsy and myoclonic seizures: an open label study. Seizure 2006; 15: 214-8.
22. Caraballo RH, Cerosimo RO, Sakr D, Cresta A, Escobal N, Fejerman N. Ketogenic diet in patients with myoclonic-astatic epilepsy. Epileptic Disord 2006; 8: 151-5.
23. Rubenstein JE, Kossoff EH, Pyzik PL, Vining EP, McGrogan JR, Freeman JM. Experience in the use of the ketogenic diet as early therapy. J Child Neurol 2005; 20: 31-4.
24. Kossoff EH, Zupec-Kania BA, Amark PE, et al. Optimal clinical management of children receiving the ketogenic diet: recommendations of the international ketogenic diet study group. Epilepsia 2009; 50: 304-17.
25. Buoni S, Mariottini A, Pieri S, et al. Vagus nerve stimulation for drug-resistant epilepsy in children and young adults. Brain Dev 2004; 26: 158-63.
26. Kaminska A, Ickowicz A, Plouin P, Bru MR, Dellatolas G, Dulac O. Delineation of cryptogenic Lennox-Gastaut syndrome and myoclonic astatic epilepsy using multiple correspondence analysis. Epilepsy Res 1999; 36: 15-29.
27. Mikaeloff Y, De Saint-Martin A, Mancini J, et al. Topiramate: efficacy and tolerability in children according to epilepsy syndromes. Epilepsy Res 2003; 53: 225-32.